WCLC 2022 Conference Coverage


 

Lecture Summary - WCLC 2022 Phase II Study of ctDNA Directed Consolidation Durvalumab After Induction and Concurrent Durvalumab With SABR for Stage I NSCLC

35 views
August 23, 2022
Comments 0
Login to view comments. Click here to Login